derivados de bifenil restritos estruturalmente para uso como inibidores do vírus da hepatite c

The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.

Saved in:
Bibliographic Details
Main Authors Makonen Belema, Carol Bachand, Jeffrey Lee Romine, David R. Langley, Fukang Yang, Daniel H. Deon, Van N. Nguyen, Lawrence G. Hamann, Clint A. James, Nicholas A. Meanwell, Omar D. Lopez, Edward H. Ruediger, Jason Goodrich, Rico Lavoie, Alain Martel, ANDREW C. GOOD, Lawrence B. Snyder, Denis R. St. Laurent, Gan Wang
Format Patent
LanguagePortuguese
Published 24.09.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure relates to compounds, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.
Bibliography:Application Number: BR2009PI08456